Autres langues Amgen Inc.

Actions

AMGN

US0311621009

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 14/02/2025			Varia. 5j.	Varia. 1 janv.
291,16 ^USD	-1,16 %		-0,81 %	+11,71 %

09:32	Un initié d'Amgen a vendu des actions d'une valeur de 2 585 644 dollars, selon un récent dépôt auprès de la SEC	MT
12/02	Amgen Inc. Presents at Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025, Feb-12-2025 11:20 AM

Autres langues

AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT	22:02
Amgen Insider Sold Shares Worth $2,585,644, According to a Recent SEC Filing	09:32
HyClone Seeks To Quash Amgen's Subpoena Issued In Denosumab BPCIA Litigation Against Fresenius	12/02
Amgen Insider Sold Shares Worth $7,341,123, According to a Recent SEC Filing	11/02
AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE	10/02
Hansoh Pharmaceutical Says IgG4-Related Disease Drug Gets Priority Review from China Regulator	10/02
AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE	07/02
Aktien Schweiz Schluss: SMI wieder über 12'600 Zählern	06/02
Trump faces pressure from US industry over China tariff on medicines	06/02
Equities Rise Amid Macro Data, Earnings; Alphabet Shares Tumble	05/02
Equities Rise as Markets Parse Macro Data, Corporate Earnings	05/02
Equities Mixed After Macro Data, Corporate Earnings	05/02
Macro Data, Corporate Earnings Leave Equity Markets Mixed Intraday	05/02
Wall Street weer lichtgroen gekleurd	05/02
Amgen: EPS up 13% in Q4	05/02
Amgen profits rise, next MariTide studies start by mid-year	04/02
Amgen überrascht positiv mit Quartal und Prognose - Kurs dennoch unter Druck	04/02
Amgen : Highlights from Amgen’s 2024 Fourth Quarter and Full Year Earnings Report	04/02
Amgen 4Q Sales Up 11% as Ten Products Post Double-Digit Gains	04/02
Amgen Seeks Acquisitions	04/02
Amgen Q4 Non-GAAP EPS, Revenue Grow; 2025 Guidance Set	04/02
Amgen: Q4 Earnings Snapshot	04/02
Amgen profit beats estimates, next MariTide studies start by mid-year	04/02
Tranche Update on Amgen Inc.'s Equity Buyback Plan announced on April 21, 2011.	04/02
Amgen Guides For FY 2025 EPS of $20.00-$21.20 on Revenue of $34.3-$35.7 Billion, vs FactSet Analyst Consensus of $20.92/Share on Revenue of $34.6 Billion	04/02

Devenez membre pour accéder à plus d'actualités

Inscription 100% Gratuite

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Amgen Inc.

Actions

AMGN

US0311621009

Produits pharmaceutiques

Autres langues

Filtres